title: Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy.
authors.forename: C A
authors.initials: CA
authors.lastname: Deminie
authors.forename: C M
authors.initials: CM
authors.lastname: Bechtold
authors.forename: K
authors.initials: K
authors.lastname: Riccardi
authors.forename: R E
authors.initials: RE
authors.lastname: Rose
authors.forename: H
authors.initials: H
authors.lastname: Samanta
authors.forename: P F
authors.initials: PF
authors.lastname: Lin
authors.forename: R J
authors.initials: RJ
authors.lastname: Colonno
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002478:Cells, Cultured; D004279:DNA, Viral / Q000235:genetics; D004352:Drug Resistance, Microbial / Q000235:genetics; D016655:HIV Core Protein p24 / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000276:immunology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D011995:Recombination, Genetic; D018119:Stavudine / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D016655:HIV Core Protein p24; D018119:Stavudine